HSG Discusses the Importance of Participation & Retention in Clinical Trials

HSG Discusses the Importance of Participation & Retention in Clinical Trials

Publication date: Mar 06, 2019

Daniel Claassen, MD Lead Investigator at HSG’s Vanderbilt University Medical Center site and Director of the Huntington’s Disease Center of ExcellenceMember of the HSG Research Advisory BoardAssociate Professor of Neurology at Vanderbilt UniversityServes as Editor for the Huntington Study Group’s bi-annual journal, HD Insights Jody Core-Bloom, MD, PhD Lead Investigator at HSG’s UC-San Diego Health site and long-time member the HSG for over 20 years and member of the HSG Research Advisory BoardDirector of the UCSD Huntington’s Disease Clinical Research Program and Center of ExcellencePrinciple Investigator on over 40 clinical trials

Concepts Keywords
Air Treating cancer
Alabama Albums
Amazing Day Therapy
Arkansas English-language films
Astros TimedText:NSApolygraphvideo.webm.en.srt
Austin Testing protocols
Bear Cancer therapy
California Diabetes
CEO Cancer
Clinical Trial Chronic condition
Clinical Trials Dreadful disease
Cognition Cognitive symptoms
Cognitive Social media platforms
Comb Law enforcement leadership
Community Radio Cancer therapy
Cross
Diabetes
Dime
Dio
Disability
Drag
Europe
False Negative
Fat
FDA
Feeling Good
Force
Gapping
Genentech
Genetic Testing
Gosh
HBO
Honey
Horizon
Huntington
Informed Consent
Inn
Insulin
ITunes
Ivf
IVF
Kansas
Khun
Korea
Las Vegas
Live Event
Lock
Memory
Neurologist
Neurology
Northern California
PhD
Pitcher
Placebo
Principal Investigator
Protocol
PSI
Puerto Rico
Sacramento
San Diego
Social Media
Southern Cal
Statistician
Sugar
Symptom
Talk Radio
Texas
Thankful
Trot
Tuning
UCSD
United States
Vanderbilt
West Coast
Wichita
YouTube

Semantics

Type Source Name
gene UNIPROT NAA50
gene UNIPROT PDC
gene UNIPROT MFN2

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *